Digest Network Come funziona
Network
/
Società
Tr
Non verificato

TreeFrog Therapeutics

Di cosa scriviamo

BiologiaFarmaceuticaIndustriaSanitàScienza

6 comunicati stampa

Guarda tutti i comunicati
25/05/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Fiere
Industria
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0
16/12/2025
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0
27/05/2025
TreeFrog Therapeutics Secures €30 Million From European Investment Bank (EIB) Marking a Significant Milestone in the Company’s Journey to Accelerate the Field of Cell Therapy
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0
13/05/2025
Eventi
Industria
Scienza
Biotecnologia
Sanità
Salute
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0
23/10/2024
Mercato del lavoro
Industria
Scienza
Biotecnologia
Sanità
Salute
Oncologia
TreeFrog Therapeutics Enters Into Pioneering Research Collaboration in Immuno-Oncology With the University of Pittsburgh
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0
01/10/2024
TreeFrog Publishes Results of First Successful Bioproduction of a Parkinson’s Disease Cell Therapy in Scalable Bioreactor in Neurotherapeutics Journal
Fonte
TreeFrog Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0